(Q39609482)

13 September 2017

title

microRNA biomarkers in body fluids of prostate cancer patients (English)

1 reference

13 September 2017

0 references

1 reference

1 reference

Ruprecht Kuner

1

1 reference

13 September 2017

Jan C Brase

series ordinal

2

1 reference

13 September 2017

Holger Sültmann

series ordinal

3

1 reference

13 September 2017

Daniela Wuttig

series ordinal

4

1 reference

13 September 2017

publication date

29 May 2012

1 reference

13 September 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Methods

1 reference

13 September 2017

volume

59

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

132-137

1 reference

Developing therapeutic microRNAs for cancer

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Serum microRNAs as non-invasive biomarkers for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Prostate-cancer screening--what the U.S. Preventive Services Task Force left out

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

7 January 2021

Overdiagnosis in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Mortality results from a randomized prostate-cancer screening trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Screening and prostate-cancer mortality in a randomized European study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Antibody-based detection of ERG rearrangement-positive prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Role of the TMPRSS2-ERG gene fusion in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

ETS gene fusions in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Interaction of Nkx3.1 and p27kip1 in prostate tumor initiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Molecular Detection of Localized Prostate Cancer Using Quantitative Methylation-Specific PCR on Urinary Cells Obtained Following Prostate Massage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Targeting continued androgen receptor signaling in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

MicroRNA expression profiling in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Detection of cancer with serum miRNAs on an oligonucleotide microarray

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Circulating microRNAs as stable blood-based markers for cancer detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

mRNA expression signature of Gleason grade predicts lethal prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Protein-coding and microRNA biomarkers of recurrence of prostate cancer following radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Integrative genomic profiling of human prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Gene networks and microRNAs implicated in aggressive prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

MicroRNA expression profiles classify human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

A microRNA expression signature of human solid tumors defines cancer gene targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Widespread deregulation of microRNA expression in human prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

The microRNA profile of prostate carcinoma obtained by deep sequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

MicroRNA profile analysis of human prostate cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Targeting microRNAs in cancer: rationale, strategies and challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Metastamirs: a stepping stone towards improved cancer management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

miRBase: integrating microRNA annotation and deep-sequencing data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

The microRNA spectrum in 12 body fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Microvesicles Released from Human Renal Cancer Stem Cells Stimulate Angiogenesis and Formation of Lung Premetastatic Niche

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

MicroRNAs in body fluids--the mix of hormones and biomarkers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Hematopoietic-specific microRNA expression in human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Haemolysis during sample preparation alters microRNA content of plasma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Analysis of circulating microRNA: preanalytical and analytical challenges.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Blood-based miRNA preparation for noninvasive biomarker development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Isolation of exosomes for subsequent mRNA, MicroRNA, and protein profiling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Circulating miRNAs are correlated with tumor progression in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

MicroRNA profiling using fluorescence-labeled beads: data acquisition and processing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Label-free SERS detection of microRNA based on affinity for an unmodified silver nanorod array substrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Innovative electrochemical approach for an early detection of microRNAs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Changes in circulating microRNA levels associated with prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

A panel of five circulating microRNAs as potential biomarkers for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Androgen regulation of micro-RNAs in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.05.004

10.1016/J.YMETH.2012.05.004

7 January 2021

Identifiers

DOI

1 reference

13 September 2017

1 reference